IRCT20180115038379N1 IRCT 2018-04-09 Shahroud University of Medical Sciences The effect of magnesium hydroxide on urinary symptoms caused by benign prostatic hyperplasia Comparison of magnesium hydroxide and tamsulosin with tamsulosin alone on urinary symptoms in patients with benign prostatic hyperplasia 2017-08-23 anticipated 96 Complete https://irct.ir/trial/28975 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Sample allocation was performed through block randomization (quadruple blocks). We named the intervention group "A" and the control group "B". Blocks were numbered using random numbers derived from random number table. The entry of individuals into each group was done based on the selected block' number. 49 patients were placed in the intervention group and 47 patients were placed in the control group, Blinding description: This study is a double-blind clinical trial and will be blind to researchers (observers) and patients (subjects). 3 Benign prostate hyperplasia. Intervention 1: Intervention group: Magnesium hydroxide 8% is the main intervention and is administered at a dose of 30 cc per night, and tamsulosin capsules are given at a dose of 0.4 mg overnight. Intervention 2: Control group: All people receive only tamsulosin capsule, 0.4 mg, every night. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is No more information